Capital International Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66B | Sell |
|
|||||
|
2025
Q1 | $2.53B | Sell |
|
|||||
|
2024
Q4 | $3.37B | Buy |
|
|||||
|
2024
Q3 | $3.52B | Buy |
|
|||||
|
2024
Q2 | $3.29B | Buy |
|
|||||
|
2024
Q1 | $3.01B | Buy |
|
|||||
|
2023
Q4 | $2.56B | Sell |
|
|||||
|
2023
Q3 | $2.45B | Buy |
|
|||||
|
2023
Q2 | $2.12B | Buy |
|
|||||
|
2023
Q1 | $1.77B | Buy |
|
|||||
|
2022
Q4 | $1.1B | Sell |
|
|||||
|
2022
Q3 | $1.22B | Sell |
|
|||||
|
2022
Q2 | $1.06B | Buy |
|
|||||
|
2022
Q1 | $1.18B | Buy |
|
|||||
|
2021
Q4 | $168M | Sell |
|
|||||
|
2021
Q3 | $685M | Sell |
|
|||||
|
2021
Q2 | $721M | Sell |
|
|||||
|
2021
Q1 | $610M | Sell |
|
|||||
|
2020
Q4 | $659M | Sell |
|
|||||
|
2020
Q3 | $808M | Sell |
|
|||||
|
2020
Q2 | $979M | Sell |
|
|||||
|
2020
Q1 | $792M | Buy |
|
|||||
|
2019
Q4 | $570M | Buy |
|
|||||
|
2019
Q3 | $421M | Buy |
|
|||||
|
2019
Q2 | $475M | Sell |
|
|||||
|
2019
Q1 | $648M | Buy |
|
|||||
|
2018
Q4 | $571M | Sell |
|
|||||
|
2018
Q3 | $703M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $37.7M | Buy |
|
|||||
|
2016
Q2 | $32.6M | Buy |
|
|||||
|
2016
Q1 | $33.6M | Buy |
|
|||||
|
2015
Q4 | $50.6M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $18K | Buy |
|